508 related articles for article (PubMed ID: 20176118)
1. Troubleshooting computational methods in drug discovery.
Kortagere S; Ekins S
J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
[TBL] [Abstract][Full Text] [Related]
2. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties.
Gupta RR; Gifford EM; Liston T; Waller CL; Hohman M; Bunin BA; Ekins S
Drug Metab Dispos; 2010 Nov; 38(11):2083-90. PubMed ID: 20693417
[TBL] [Abstract][Full Text] [Related]
3. Toxicology Strategies for Drug Discovery: Present and Future.
Blomme EA; Will Y
Chem Res Toxicol; 2016 Apr; 29(4):473-504. PubMed ID: 26588328
[TBL] [Abstract][Full Text] [Related]
4. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
5. Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.
Clark AM; Dole K; Coulon-Spektor A; McNutt A; Grass G; Freundlich JS; Reynolds RC; Ekins S
J Chem Inf Model; 2015 Jun; 55(6):1231-45. PubMed ID: 25994950
[TBL] [Abstract][Full Text] [Related]
6. Mind the Gap! A Journey towards Computational Toxicology.
Mangiatordi GF; Alberga D; Altomare CD; Carotti A; Catto M; Cellamare S; Gadaleta D; Lattanzi G; Leonetti F; Pisani L; Stefanachi A; Trisciuzzi D; Nicolotti O
Mol Inform; 2016 Sep; 35(8-9):294-308. PubMed ID: 27546034
[TBL] [Abstract][Full Text] [Related]
7. Toxicology Strategies for Drug Discovery - Present and Future: Introduction.
Humphreys WG; Will Y; Guengerich FP
Chem Res Toxicol; 2016 Apr; 29(4):437. PubMed ID: 27087588
[No Abstract] [Full Text] [Related]
8. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
9. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence in drug design.
Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
[TBL] [Abstract][Full Text] [Related]
11. Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations.
Singh PK; Negi A; Gupta PK; Chauhan M; Kumar R
Arch Toxicol; 2016 Aug; 90(8):1785-802. PubMed ID: 26341667
[TBL] [Abstract][Full Text] [Related]
12. In silico ADME-Tox modeling: progress and prospects.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
Khakar PS
Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
[TBL] [Abstract][Full Text] [Related]
14. QSAR Methods.
Gini G
Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
[TBL] [Abstract][Full Text] [Related]
15. Troubleshooting pharmacological and toxicological methods.
Curtis MJ
J Pharmacol Toxicol Methods; 2010; 61(2):65-6. PubMed ID: 20184960
[TBL] [Abstract][Full Text] [Related]
16. Computational prediction of human drug metabolism.
Ekins S; Andreyev S; Ryabov A; Kirillov E; Rakhmatulin EA; Bugrim A; Nikolskaya T
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):303-24. PubMed ID: 16922645
[TBL] [Abstract][Full Text] [Related]
17. Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development.
Ekins S; Williams AJ
Lab Chip; 2010 Jan; 10(1):13-22. PubMed ID: 20024044
[TBL] [Abstract][Full Text] [Related]
18. Toxicology in the drug discovery and development process.
Dorato MA; Buckley LA
Curr Protoc Pharmacol; 2006 Apr; Chapter 10():Unit10.3. PubMed ID: 22294168
[TBL] [Abstract][Full Text] [Related]
19. Enalos Suite: New Cheminformatics Platform for Drug Discovery and Computational Toxicology.
Varsou DD; Nikolakopoulos S; Tsoumanis A; Melagraki G; Afantitis A
Methods Mol Biol; 2018; 1800():287-311. PubMed ID: 29934899
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry imaging in drug development.
Nilsson A; Goodwin RJ; Shariatgorji M; Vallianatou T; Webborn PJ; Andrén PE
Anal Chem; 2015 Feb; 87(3):1437-55. PubMed ID: 25526173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
